Screener
Moderna MRNA Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Moderna in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The source filing: Moderna’s 8-K, filed July 31, 2026. Open the filing →
- Filed
- Jul 31, 2026, 7:03 AM EDT
- Accession
- 0001682852-26-000147
FAQ
- What is Moderna's accrued expenses?
- Moderna (MRNA) reported accrued expenses of $1.91B in Q2 2026.
- How has Moderna's accrued expenses changed year-over-year?
- Moderna's accrued expenses increased by 869.0% year-over-year, from $197M to $1.91B.
- What is the long-term trend for Moderna's accrued expenses?
- Over 5 years (2020 to 2025), Moderna's accrued expenses has grown at a 65.3% compound annual growth rate (CAGR), from $34M to $420M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.
Ask your AI about Moderna's accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude